Ervebo, an Ebola vaccine from Merck, received marketing approval from the European Commission today (November 11), marking the first such vaccine to reach the world’s markets. (source: the-scientist.com)
Ervebo, an Ebola vaccine from Merck, received marketing approval from the European Commission today (November 11), marking the first such vaccine to reach the world’s markets. (source: the-scientist.com)